Evofem Biosciences, Inc. (EVFM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
4,842
446
0
0
0
Cost of Revenue
2,451
468
-
-
-
Gross Profit
2,391
-22
-
-
-
Operating Expenses
Research Development
30,416
17,050
22,230
43,415
3,946
Selling General and Administrative
137,209
86,552
30,512
34,227
6,099
Total Operating Expenses
167,625
103,602
52,742
77,642
10,045
Operating Income or Loss
-165,234
-103,624
-52,742
-77,642
-10,045
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
-29,020
-38,850
-27,745
-48,195
-
Income Before Tax
-194,223
-142,305
-80,029
-125,710
-9,993
Income Tax Expense
13
4
4
2
-
Income from Continuing Operations
-194,236
-142,309
-80,033
-125,712
-9,993
Net Income
-194,236
-142,309
-80,033
-125,712
-9,993
Net Income available to common shareholders
-194,236
-142,309
-80,033
-125,778
-9,993
Basic EPS
-
-2.12
-1.99
-5.74
-4.33
Diluted EPS
-
-2.12
-1.99
-5.74
-4.33
Basic Average Shares
-
67,157
40,229
21,901
2,305
Diluted Average Shares
-
67,157
40,229
21,901
2,305
EBITDA
-
-103,322
-52,479
-77,380
-9,948
